MARKET

NNVC

NNVC

Nanoviricides
AMEX
1.690
+0.100
+6.29%
After Hours: 1.680 -0.01 -0.59% 16:13 09/28 EDT
OPEN
1.570
PREV CLOSE
1.590
HIGH
1.740
LOW
1.570
VOLUME
47.87K
TURNOVER
0
52 WEEK HIGH
5.56
52 WEEK LOW
1.040
MARKET CAP
19.53M
P/E (TTM)
-2.3176
1D
5D
1M
3M
1Y
5Y
NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly
By Rachael Green, Benzinga
News Direct · 09/19 13:26
Watching NanoViricides Shares As Traders Circulate Article 'Nanotechnology-based strategies against SARS-CoV-2 variants'
https://www.nature.com/articles/s41565-022-01174-5
Benzinga · 08/18 17:56
Monkeypox Is Popping Up In Places It Shouldn’t But NanoViricides Says It May Have A Solution
Benzinga - Rachel Green
News Direct · 08/10 12:00
NanoViricides Provides Additional Details on Its Rapid Monkeypox Drug Strategy -
NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, provides further details on its rapid drug development strategy for Monkeypox vir...
Benzinga · 08/09 10:47
Short Volatility Alert: NanoViricides, Inc.
On Thursday, shares of NanoViricides, Inc. (NYSE: NNVC) experienced volatile short activity. After the activity, the stock price went up +48.37% to $3.65. The overall sentiment for NNVC has been Neutral.
Benzinga · 08/05 16:23
Sector Update: Health Care Stocks Slipping Ahead of Thursday Close
Sector Update: Health Care Stocks Slipping Ahead of Thursday Close
MT Newswires · 08/04 15:52
InVivo, ChemoCentryx top healthcare gainers; Helius, Enveric lead losers' pack
Gainers: InVivo Therapeutics (NVIV) +114%. Che...
Seekingalpha · 08/04 14:04
Sector Update: Health Care Stocks Sputtering Despite Surging Biotechs
Sector Update: Health Care Stocks Sputtering Despite Surging Biotechs
MT Newswires · 08/04 13:56
More
About NNVC
NanoViricides, Inc. is a nano-biopharmaceutical company. The Company is engaged in discovery, development, and commercialization of drugs to combat viral infections using its nanomedicines technology. The Company's nanoviricide technology enables direct attacks at multiple points on a virus particle. The nanomedicines technology also enables attacking the rapid intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The Company is developing antiviral drug candidate, NV-CoV-2 drug for the treatment of COVID-19 infected sick persons. Its other clinical drug candidate NV-HHV-101 a skin cream for the treatment of shingles rash.

Webull offers kinds of NanoViricides Inc stock information, including AMEX:NNVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NNVC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NNVC stock methods without spending real money on the virtual paper trading platform.